Cambridge Investment Research Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 13, 2023
SELL
$21.06 - $24.0 $6.4 Million - $7.29 Million
-303,957 Reduced 96.34%
11,549 $248,000
Q1 2023

May 11, 2023
SELL
$23.0 - $29.88 $25,737 - $33,435
-1,119 Reduced 0.35%
315,506 $7.57 Million
Q4 2022

Feb 08, 2023
BUY
$16.14 - $23.55 $4 Million - $5.83 Million
247,697 Added 359.36%
316,625 $7.35 Million
Q3 2022

Oct 17, 2022
BUY
$15.46 - $20.1 $1.07 Million - $1.39 Million
68,928 New
68,928 $1.1 Million

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email